CONDENSED CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		8 Months Ended
	Sep. 05, 2026	Sep. 06, 2025	Sep. 05, 2026	Sep. 06, 2025
Net Revenue	$ 25,274	$ 23,937	$ 68,898	$ 64,582
Cost of sales	11,520	11,113	31,302	29,343
Gross profit	13,754	12,824	37,596	35,239
Selling, general and administrative expenses	9,494	9,122	26,100	25,305
Intangible Asset, Excluding Goodwill, Indefinite-Lived, Impairment Loss	0	133	0	1,993
Operating Profit	4,260	3,569	11,496	7,941
Other pension and retiree medical benefits (expense)/income	(114)	26	3	91
Net interest expense and other	(242)	(264)	(773)	(788)
Income before income taxes	3,904	3,331	10,726	7,244
Provision for income taxes	834	713	2,314	1,504
Net income	3,070	2,618	8,412	5,740
Less: Net income attributable to noncontrolling interests	22	15	56	40
Net Income Attributable to PepsiCo	$ 3,048	$ 2,603	$ 8,356	$ 5,700
Net Income Attributable to PepsiCo per Common Share
Basic	$ 2.23	$ 1.90	$ 6.12	$ 4.16
Diluted	$ 2.23	$ 1.90	$ 6.10	$ 4.15
Weighted-average common shares outstanding
Basic	1,364	1,369	1,366	1,370
Diluted	1,367	1,372	1,369	1,373

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	8 Months Ended
	Sep. 05, 2026	Sep. 06, 2025
Operating Activities
Net income	$ 8,412	$ 5,740
Depreciation and amortization	2,531	2,315
Impairment and other charges	0	1,960
Operating lease right-of-use asset amortization	531	489
Share-based compensation expense	240	207
Restructuring and impairment charges	367	567
Cash payments for restructuring charges	(373)	(554)
Acquisition and divestiture-related charges/credits	(254)	308
Cash payments for acquisition and divestiture-related charges	(24)	(80)
Pension and retiree medical plan expenses	227	164
Pension and retiree medical plan contributions	(355)	(400)
Deferred income taxes and other tax charges/credits	663	30
Tax payments related to the Tax Cuts and Jobs Act (TCJ Act)	(965)	(772)
Change in assets and liabilities:
Accounts and notes receivable	(2,124)	(1,747)
Inventories	(588)	(449)
Prepaid expenses and other current assets	27	(223)
Accounts payable and other current liabilities	(358)	(1,647)
Income taxes payable	415	6
Other, net	(422)	(446)
Net Cash Provided by Operating Activities	7,950	5,468
Investing Activities
Capital spending	(2,182)	(2,499)
Sales of property, plant and equipment	89	272
Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets	(148)	(3,176)
Short-term investments, by original maturity:
Payments to Acquire Short-Term Investments	(105)	(190)
More than three months - maturities	17	425
Proceeds from Sale of Debt Securities, Available-for-Sale	14	0
Payments for (Proceeds from) Short-term investments, three months or less, net	(5)	43
Other investing, net	(27)	(112)
Net Cash Used for Investing Activities	(2,347)	(5,237)
Financing Activities
Proceeds from issuances of long-term debt	2,978	8,179
Payments of long-term debt	(2,328)	(3,245)
Short-term borrowings, by original maturity:
More than three months - proceeds	4,562	5,528
More than three months - payments	(3,817)	(5,417)
Three months or less, net	1,365	445
Cash dividends paid	(5,935)	(5,692)
Share repurchases	(739)	(752)
Proceeds from exercises of stock options	107	76
Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted	(96)	(112)
Other financing	(1)	(18)
Net Cash Used for Financing Activities	(3,904)	(1,008)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(175)	395
Net Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash	1,524	(382)
Cash and Cash Equivalents and Restricted Cash, Beginning of Year	9,204	8,553
Cash and Cash Equivalents and Restricted Cash, End of Period	10,728	8,171
Supplemental Non-Cash Activity
Right-of-use assets obtained in exchange for lease obligations	625	542
Purchase Commitment (Celsius) [Abstract]	$ 0	$ 554

CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) shares in Thousands, $ in Millions	Sep. 05, 2026	Dec. 27, 2025
Current Assets
Cash and cash equivalents	$ 10,675	$ 9,159
Short-term investments	488	371
Accounts and Financing Receivable, after Allowance for Credit Loss, Current	13,623	11,506
Inventories:
Raw materials and packaging	2,792	2,581
Work-in-process	175	143
Finished goods	3,467	3,121
Inventory, Net, Total	6,434	5,845
Prepaid expenses and other current assets	1,339	1,068
Total Current Assets	32,559	27,949
Property, plant and equipment	62,383	60,909
Accumulated depreciation	(32,652)	(31,004)
Property, Plant and Equipment, net	29,731	29,905
Amortizable Intangible Assets, net	1,165	1,219
Goodwill	18,884	18,916
Intangible Asset, Excluding Goodwill, Indefinite-Lived	13,977	13,847
Investments in Noncontrolled Affiliates	2,215	2,038
Deferred Income Taxes	4,328	4,541
Other Assets	9,117	8,984
Total Assets	111,976	107,399
Current Liabilities
Short-term debt obligations	9,223	6,861
Accounts payable and other current liabilities	25,306	25,903
Total Current Liabilities	34,529	32,764
Long-Term Debt Obligations	42,658	42,321
Deferred Income Taxes	4,107	3,802
Other Liabilities	8,195	7,965
Total Liabilities	$ 89,489	$ 86,852
Common stock, issued (in shares)	1,364,000	1,367,000
PepsiCo Common Shareholders’ Equity
Common stock, par value 12/3¢ per share (authorized 3,600 shares; issued, net of repurchased common stock at par value: 1,364 and 1,367 shares, respectively)	$ 23	$ 23
Capital in excess of par value	4,522	4,451
Retained earnings	75,140	72,788
Accumulated other comprehensive loss	(14,987)	(15,024)
Repurchased common stock, in excess of par value (503 and 500 shares, respectively)	(42,406)	(41,832)
Total PepsiCo Common Shareholders’ Equity	22,292	20,406
Noncontrolling interests	195	141
Total Equity	22,487	20,547
Total Liabilities and Equity	$ 111,976	$ 107,399
Treasury Stock, Common, Shares	503,000	500,000
Common stock, authorized (in shares)	3,600,000	3,600,000